プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Melisa S.に依頼

United States

Clinical Researcher and Scientist

プロフィール概要

Experienced researcher with scientific knowledge and expertise in several therapeutic areas, including: metabolic disorders, ophthalmology, gene therapy, oncology, stem cell transplantation, rare diseases, gastroenterology, infectious diseases; hands on experience writing manuscripts, reports, book chapters; fluent in Spanish (native language) and Italian (intermediate in writing and spoken). Also, background in pharmacovigilance, clinical research coordination, regulatory affairs and patient healthcare.

専門分野

• ★ Clinical Trials
• ★ Pharmacovigilance/Drug Safety Monitoring
• ☆ Virology
• ☆ Retrovirology
• ☆ Immunoassay
• ☆ Molecular Biology
• ☆ Genetics
• ☆ Stem Cell Research
• ☆ Basic Immunology
• ☆ Biotechnology & Bioengineering
• ☆ Database Management
• ☆ Data Analysis
• ☆ Data Management
• ☆ Spanish
• ☆ Italian
• ☆ Ophthalmology
• ☆ Pediatric Medicine
• ☆ Oncology
• ☆ Gastroenterology & Hepatology
• ☆ Diabetes
• ☆ Hematology
• ☆ Infectious Disease
• ☆ Organ Transplant
• ☆ Rare Diseases
• ☆ Home Health Care
• ☆ Regulatory Affairs
• ☆ Gene Therapy
• ☆ Manuscript & Journal Article Writing

サービス

• Writing
• Research
• Consulting
• Data & AI
• Product Development

職務経験

Safety Reporting Administrator

Pharmaceutical Product Development Inc

7月 2017 - 現在

Freelance translator Spanish-English

Cactus Communications Inc

3月 2017 - 現在

Clinical Research Associate

Pharmaceutical Product Development Inc

7月 2019 - 7月 2021

Freelance editor

Enago

3月 2017 - 7月 2017

Clinical Research Fellow

University of North Carolina at Chapel Hill

10月 2016 - 6月 2017

Clinical Research Fellow

University of North Carolina Hospitals

8月 2016 - 10月 2016

Regulatory Affairs Intern

Chiesi Pharmaceuticals Inc

8月 2016 - 10月 2016

Post-doctoral Research Associate Fellow

North Carolina State University

8月 2014 - 7月 2016

Post-doctoral Research Fellow

Wake Forest School of Medicine

2月 2011 - 7月 2014

Graduate Research Assistant

University of Nevada Reno

2月 2006 - 12月 2010

学歴

Medical Product Safety and Pharmacovigilance Certificate

Durham Technical Community College

2017 - 現在

Data Management Certificate

Durham Technical Community College

2017 - 現在

Ph.D in Cellular and Molecular Biology

University of Nevada Reno

1月 2006 - 12月 2010

Licenciatura en Biotecnologia (Equivalent to a Master In Biotechnology)

Universidad Nacional de Rosario Facultad de Ciencias Bioquimicas y Farmaceuticas

3月 1996 - 4月 2005

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Vance, M., Llanga, T., Bennett, W., Woodard, K., Murlidharan, G., Vance, M., Llanga, T., Bennett, W., Woodard, K., Murlidharan, G., et al.(2016). AAV Gene Therapy for MPS1-associated Corneal Blindness . Scientific Reports. 6.

(2014). Evaluation of gene delivery strategies to efficiently over-express functional hla-G on human bone marrow stromal cells. Molecular Therapy.

(2014). Perivascular stromal cells as a potential reservoir of human cytomegalovirus . American Journal of Transplantation. 14. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 820-830.

Soland, M.A., Bego, M., Colletti, E., Zanjani, E.D., St. Jeor, S., Porada, C.D., Almeida-Porada, G.(2013). Mesenchymal Stem Cells Engineered to Inhibit Complement-Mediated Damage . PLoS ONE. 8. (3).

Almeida-Porada, G., Soland, M., Boura, J., Porada, C.D.(2013). Regenerative medicine: Prospects for the treatment of inflammatory bowel disease . Regenerative Medicine. 8. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 631-644.

(2013). Mesenchymal stem cells contribute to endogenous FVIII: C production . Journal of Cellular Physiology. 228. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1010-1016.

(2013). EphB2 isolates a human marrow stromal cell subpopulation with enhanced ability to contribute to the resident intestinal cellular pool . FASEB Journal. 27. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2111-2121.

(2012). HCMV Protein LUNA Is Required for Viral Reactivation from Latently Infected Primary CD14⁺Cells . PLoS ONE. 7. (12).

(2012). Cyclophilin A is required for efficient human cytomegalovirus DNA replication and reactivation . Journal of General Virology. 93. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 722-732.

(2012). Modulation of human mesenchymal stem cell immunogenicity through forced expression of human cytomegalovirus US proteins . PLoS ONE. 7. (5).

Soland, M.(2011). Modulation of mesenchymal stem cell immunogenicity through stable expression of human cytomegalovirus proteins . Rejuvenation Research. 14. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 342-343.

BOOK CHAPTER

(2015). AAV Biology, Infectivity and Therapeutic Use from Bench to Clinic . Gene Therapy Principles and Challenges.